1. Home
  2. ROMA vs CYBN Comparison

ROMA vs CYBN Comparison

Compare ROMA & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROMA
  • CYBN
  • Stock Information
  • Founded
  • ROMA 2018
  • CYBN 2019
  • Country
  • ROMA Hong Kong
  • CYBN Canada
  • Employees
  • ROMA N/A
  • CYBN N/A
  • Industry
  • ROMA Savings Institutions
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • ROMA Finance
  • CYBN Health Care
  • Exchange
  • ROMA Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • ROMA 150.7M
  • CYBN 176.5M
  • IPO Year
  • ROMA 2024
  • CYBN N/A
  • Fundamental
  • Price
  • ROMA $2.76
  • CYBN $6.43
  • Analyst Decision
  • ROMA
  • CYBN Strong Buy
  • Analyst Count
  • ROMA 0
  • CYBN 3
  • Target Price
  • ROMA N/A
  • CYBN $85.00
  • AVG Volume (30 Days)
  • ROMA 82.9K
  • CYBN 695.5K
  • Earning Date
  • ROMA 09-25-2025
  • CYBN 11-12-2025
  • Dividend Yield
  • ROMA N/A
  • CYBN N/A
  • EPS Growth
  • ROMA N/A
  • CYBN N/A
  • EPS
  • ROMA N/A
  • CYBN N/A
  • Revenue
  • ROMA $1,568,345.00
  • CYBN N/A
  • Revenue This Year
  • ROMA N/A
  • CYBN N/A
  • Revenue Next Year
  • ROMA N/A
  • CYBN N/A
  • P/E Ratio
  • ROMA N/A
  • CYBN N/A
  • Revenue Growth
  • ROMA 23.21
  • CYBN N/A
  • 52 Week Low
  • ROMA $0.58
  • CYBN $4.81
  • 52 Week High
  • ROMA $4.66
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • ROMA 46.48
  • CYBN 52.62
  • Support Level
  • ROMA $2.50
  • CYBN $5.72
  • Resistance Level
  • ROMA $3.30
  • CYBN $6.52
  • Average True Range (ATR)
  • ROMA 0.29
  • CYBN 0.32
  • MACD
  • ROMA -0.03
  • CYBN 0.08
  • Stochastic Oscillator
  • ROMA 31.71
  • CYBN 78.02

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: